about
N-acetylcysteine -- passe-partout or much ado about nothing?Genetic causation of neointimal hyperplasia in hemodialysis vascular access dysfunctionEffect of redox modulating NRF2 activators on chronic kidney diseaseOxidative stress and nucleic acid oxidation in patients with chronic kidney diseaseNiacin ameliorates oxidative stress, inflammation, proteinuria, and hypertension in rats with chronic renal failureComparison of markers of oxidative stress, inflammation and arterial stiffness between incident hemodialysis and peritoneal dialysis patients--an observational study.Time course and dose response of alpha tocopherol on oxidative stress in haemodialysis patients.Role of Oxidative Stress in the Pathogenesis of Pancreatitis: Effect of Antioxidant Therapy.Balloon-assisted maturation (BAM) of the arteriovenous fistula: the good, the bad, and the ugly.Comparison of plasma oxidative biomarkers and conformational modifications of hemoglobin in patients with diabetes on hemodialysisDecreased circulating klotho levels in patients undergoing dialysis and relationship to oxidative stress and inflammationComparative effects of silymarin and vitamin E supplementation on oxidative stress markers, and hemoglobin levels among patients on hemodialysis.Effect of extended-release niacin on cardiovascular events and kidney function in chronic kidney disease: a post hoc analysis of the AIM-HIGH trial.Comparative effects of angiotensin-converting enzyme inhibition and angiotensin-receptor blockade on inflammation during hemodialysis.Cysteinylation and homocysteinylation of plasma protein thiols during ageing of healthy human beings.Simultaneous determination of total homocysteine, cysteine, cysteinylglycine, and glutathione in human plasma by high-performance liquid chromatography: application to studies of oxidative stress.Targeting the transcription factor Nrf2 to ameliorate oxidative stress and inflammation in chronic kidney diseaseWAVE1 mediates suppression of phagocytosis by phospholipid-derived DAMPs.CKD impairs barrier function and alters microbial flora of the intestine: a major link to inflammation and uremic toxicity.Far infrared therapy inhibits vascular endothelial inflammation via the induction of heme oxygenase-1.Endogenous bradykinin contributes to increased plasminogen activator inhibitor 1 antigen following hemodialysisUrinary F2 -Isoprostanes in Cats with International Renal Interest Society Stage 1-4 Chronic Kidney Disease.Altered intestinal microbial flora and impaired epithelial barrier structure and function in CKD: the nature, mechanisms, consequences and potential treatment.Platelet proteomics applied to the search for novel antiplatelet therapeutic targets.Measurement of the intestinal permeability in chronic kidney disease.Curcumin induces Nrf2 nuclear translocation and prevents glomerular hypertension, hyperfiltration, oxidant stress, and the decrease in antioxidant enzymes in 5/6 nephrectomized rats.Protective Effect of Aqueous Extract of Terminalia arjuna against Dehydrating Induced Oxidative Stress and Uremia in Male Rat.Oxidation of Met1606 in von Willebrand factor is a risk factor for thrombotic and septic complications in chronic renal failure.Base excision repair capacity in chronic renal failure patients undergoing hemodialysis treatment.Downregulation of the renal and hepatic hydrogen sulfide (H2S)-producing enzymes and capacity in chronic kidney disease.The Chronic Kidney Disease - Colonic Axis.Myeloperoxidase serves as a marker of oxidative stress during single haemodialysis session using two different biocompatible dialysis membranes.Cytotoxic effects exerted by polyarylsulfone dialyser membranes depend on different sterilization processes.Suppression of oxidative stress in aging NZB/NZW mice: effect of fish oil feeding on hepatic antioxidant status and guanidino compounds.Melatonin ameliorates oxidative stress, inflammation, proteinuria, and progression of renal damage in rats with renal mass reduction.Increase in oxidative stress but not in antioxidant capacity with advancing stages of chronic kidney disease.Chemiluminescent analysis of plasma antioxidant capacity in uremic patients undergoing hemodialysis.Haemolysis in haemodialysis.Positive association between plasma levels of oxidized low-density lipoprotein and myeloperoxidase after hemodialysis in patients with diabetic end-stage renal disease.Evaluation of salivary parameters and dental status in adult hemodialysis patients in an indian population.
P2860
Q24678741-C6F48DC2-6E0A-4B49-8A49-FE5104E12EDFQ26824460-7F4F2FBA-C82D-4E16-9B9E-D0EC908974B2Q26827726-BD6AF34A-B468-4254-8C89-B49CCE32FEF8Q27006908-18FD9A08-173B-46CC-B9F2-E93BC30A17FBQ28566456-42590ED4-6367-4583-9BA7-B71A49C8BDC6Q30490204-829D9265-FC35-4E4C-B9CC-9EB170BD5033Q33511679-18F78519-BBA4-4EE8-96C9-81BF11CADD60Q33565856-82C22FA6-6363-4A24-A174-181A2629D5E4Q35021651-D31101D7-1B6B-4F3B-963E-A297453B1595Q35087619-F950886A-70C3-4F47-8981-C166F1ED3C08Q35106070-732F6FBC-D3FE-4AA2-B412-ECC80848F3E6Q35126099-7B586BF4-2C10-4387-BFDB-9CE8FEE5CB1AQ35667598-44383951-98F8-4040-81C8-3C141898D348Q35715691-6F73F90C-B28D-4651-9F46-657C90BA13DDQ35893247-186FAA95-E797-47D8-B9C3-49F64DB11702Q35963431-57E5FD49-5770-4626-83FB-0BE1BE251FC8Q36788430-603075E0-C96C-42C2-96BB-5F0996A1B565Q36966966-46842F87-59DA-4A15-83E4-92F680641F11Q37131182-516E6C1F-2AB6-474C-BB9E-CD38D5C53D92Q37356118-4B8E0521-1777-48EE-83DA-449746E66448Q37367707-54418F92-81D4-426E-82CD-627F89C5E754Q37705105-205A03B2-A30C-4511-B38F-DBFFB42BC78DQ38425357-EA56A4FA-3620-49C8-9299-86A4D01DA57EQ38813483-92972047-9870-474A-A391-9C28D5306774Q40599724-BB0673ED-DF49-43B1-83B3-F5B4C228202DQ42285179-9204E438-3402-41C1-8F58-EDD655F082C3Q42797440-9FCBF99C-E40F-433C-938F-DEF4CC997639Q44479370-5A061F71-ECD3-4B04-939C-35108A774158Q45330210-3EF1CE2E-E29A-43F2-AA37-7516256F1394Q45986959-DE93D7BC-EF61-492A-B9FE-BD1ADABB4C98Q46415279-CCF451DA-7888-4419-991D-CD9BD598BD1EQ46425715-66F2AF7A-2058-4903-935F-18465BF002D9Q46555135-42C1CD74-595E-4A86-8F44-6A5BA9BCB2F6Q46812952-F6E661FE-7F20-4C9C-A467-580AFA926AEFQ46852269-58A237A0-E558-4E19-A006-8A02B72DD0D7Q46862672-7D358A39-1E2B-4FD8-B0C4-A4513022071EQ47292649-BC8C387F-CDD4-4BFF-A132-FEA6D437D67DQ47819838-38D4B1D9-488A-4B21-80F7-0AE0A005480EQ51032319-C07FCE78-838F-476A-9AD0-6BE8EEE6A0A9Q55117450-19CF2259-38D4-4D6D-8E68-70671E976196
P2860
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
Oxidative stress in uremia.
@ast
Oxidative stress in uremia.
@en
type
label
Oxidative stress in uremia.
@ast
Oxidative stress in uremia.
@en
prefLabel
Oxidative stress in uremia.
@ast
Oxidative stress in uremia.
@en
P1476
Oxidative stress in uremia.
@en
P2093
Jonathan Himmelfarb
Raymond M Hakim
P304
P356
10.1097/00041552-200311000-00004
P577
2003-11-01T00:00:00Z